Filing Details
- Accession Number:
- 0001493152-17-015051
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-12-26 15:02:37
- Reporting Period:
- 2017-12-21
- Accepted Time:
- 2017-12-26 15:02:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 868278 | Prophase Labs Inc. | PRPH | Pharmaceutical Preparations (2834) | 232577138 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1457896 | William Ted Karkus | 621 N. Shady Retreat Road Doylestown PA 18901 | Ceo & Chairman | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.005 | Disposition | 2017-12-21 | 424,789 | $2.30 | 2,484,849 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- These shares were sold to the Issuer through the tender offer by the Issuer for 1,700,000 shares of its common stock.
Billionaire Hedge Funds
